Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Red Blood Cells Transfusion, Oncologic Surgery
Both
Red Blood Cells Transfusion, Oncologic Surgery
Trial Information
Inclusion Criteria:
- Patients with cancer after major abdominal surgery requiring post-operative ICU
admission
- Adults patients
Exclusion Criteria:
- Age less than 18 year
- Hematologic Malignances
- Intensive care unit permanence lower than 24 hours
- Renal Chronic Failure in Renal Replacement Therapy
- Karnofsky Status < 50
- Previous anemia (hemoglobin lower than 9 g/dL)
- Previous thrombocytopenia (platelet number lower than 50.000/mm3)
- Previous known coagulopathy
- Anticoagulation therapy
- Those unable to receive blood transfusion
- Patients who refused participation in the study
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Composite end-point of mortality and severe complication
Outcome Description:
• The primary purpose of this study is to compare clinical outcomes after oncologic surgery in patients submitted to different strategies of red blood cell transfusion
Outcome Time Frame:
30 days
Safety Issue:
Yes
Authority:
Brazil: National Committee of Ethics in Research
Study ID:
002/11
NCT ID:
NCT01502215
Start Date:
January 2012
Completion Date:
December 2012
Related Keywords:
- Red Blood Cells Transfusion
- Oncologic Surgery
Name | Location |
|---|
